- IMS Info Brochure (pdf)We Extend the Frontiers (pdf)Patient information (pdf)Second Opinion (pdf)Check ups (pdf)
Aquablation® Therapy in the Treatment of Prostate Adenoma
[18.02.2022] Applying this procedure presents a lower rate of complications and less side effects on sexual activity.
The treatment of benign enlargement of the prostate is an important focus of the Department of Urology at the Medical Center - University of Freiburg. In addition to the electroresection (TURP) and laser enucleation (HoLEP) which have been tried and well-proven for decades, the Department of Urology also performs newer minimally invasive procedures to offer patients an individually adapted therapy concept.
The AquaBeam® system is a robotic, autonomous system in which prostate tissue is removed with a waterjet without the heat dissipation that is a potential risk in other procedures.
While the surgeon provides an individual treatment plan based on the latest imaging, which is precisely adapted to the anatomy of the respective patient, the guidance of the waterjet is taken over by a high-precision robotic arm and thus achieves a high level of precision.
The procedure, which was first introduced in a study from New Zealand in 2015, has been repeatedly examined in studies in recent years and has shown an effectiveness equivalent to the standard procedure of electroresection (TURP). In addition, current study results indicate that the use of this procedure is associated with a lower rate of complications as well as a lower rate of side effects on sexual activity.